Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cure Kids Ventures (CKV) is a seed and early-stage investment fund established in 2008 and based in New Zealand. The fund is dedicated to the commercialization of innovations in products and services that can significantly benefit child health. CKV is owned by the Cure Kids Foundation, which stands as the largest private funder of child health research in New Zealand. This ownership provides CKV with a unique position in the market, allowing it to leverage extensive resources and expertise in the healthcare sector.
Over the years, CKV has built a reputation as a knowledgeable and value-added investor, particularly in the healthcare and biotech sectors. The organization has launched its third fund to continue its investment activities, focusing on emerging healthcare companies that can positively impact child health. CKV's commitment to this mission is reflected in its diverse portfolio, which includes 17 companies, and its active engagement in the venture capital landscape.
Cure Kids Ventures specializes in investing in emerging healthcare companies in New Zealand that have the potential to improve child health. The fund's investment strategy encompasses various areas, including medical devices, medications, diagnostics, health information, and healthcare delivery systems. CKV seeks to identify and support innovations that can lead to significant advancements in child health outcomes.
The fund typically invests at the pre-seed and seed stages, providing early-stage companies with not only capital but also industry-specific expertise and access to valuable networks. CKV's focus on healthcare innovation is driven by its mission to enhance child health, making it a distinctive player in the venture capital space.
Cure Kids Ventures has invested in a diverse array of notable companies, including:
CKV has also achieved notable exits, including:
Matthew McMahon: Chief Investment Manager at CKV, Matthew has extensive experience in venture capital and healthcare investments. He has led multiple successful funding rounds and has a strong background in financial analysis.
Franceska Banga: Chair of the Board, Franceska brings a wealth of experience in governance and strategic leadership within the healthcare sector. She has held various leadership roles in both public and private organizations.
Howard Moore: Director at CKV, Howard has a background in healthcare innovation and has been instrumental in identifying promising investment opportunities within the sector.
Frances Soutter: Director, Frances has a strong track record in venture capital and has worked with numerous startups to help them scale their operations effectively.
Matthew Payton: Director, Matthew specializes in healthcare investments and has a deep understanding of the challenges faced by early-stage companies in this field.
To pitch Cure Kids Ventures, founders should send an email to info@curekidsventures.co.nz. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, and how the innovation specifically benefits child health. CKV appreciates clear and concise presentations that highlight the team's expertise and the innovation's potential impact.
Response times may vary, but founders can generally expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
In recent months, Cure Kids Ventures has launched its third fund, aimed at continuing its investment activities in the healthcare sector. This new fund reflects CKV's ongoing commitment to supporting innovations that enhance child health.
CKV maintains an active presence in the venture capital landscape, focusing on identifying and supporting emerging healthcare companies. The organization has been involved in various discussions and collaborations aimed at fostering advancements in child health.
What are the investment criteria for Cure Kids Ventures?
Cure Kids Ventures invests in early-stage healthcare companies that can positively impact child health. The focus is on innovations in medical devices, medications, diagnostics, and healthcare delivery systems.
How can I pitch to Cure Kids Ventures?
Founders can pitch to CKV by sending an email to info@curekidsventures.co.nz. It is advisable to include a detailed deck that outlines the business model, market opportunity, and how the innovation benefits child health.
What makes Cure Kids Ventures different from other investors?
CKV is unique due to its ownership by the Cure Kids Foundation, which provides access to extensive resources and expertise in child health research. This connection allows CKV to offer significant value beyond capital.
What is the geographic focus of Cure Kids Ventures?
CKV primarily invests in companies based in New Zealand, specifically those that are working on innovations in healthcare that can enhance child health.
What is the typical check size for investments?
While specific check sizes are not disclosed, CKV focuses on seed and pre-seed investments, which typically range from $100,000 to $1 million, depending on the stage and needs of the company.
What kind of support do portfolio companies receive post-investment?
Cure Kids Ventures provides its portfolio companies with industry-specific expertise, access to networks, and ongoing support to help them navigate the challenges of scaling their innovations in the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.